Chao-Jung Tsao
Author
Alternate name Chao‐Jung Tsao
Institution Chi Mei Medical Center
Past institutions Chi Mei Medical Center, HTC (Taiwan), National Taiwan University, National Cheng Kung University Hospital, The University of Texas MD Anderson Cancer Center +2 more
H-index: 15
I10-index: 16
Works count: 27
Citations count: 6,524
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
2008 · Ann‐Lii Cheng, Yoon‐Koo Kang, et al. · The Lancet Oncology
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
2003 · Ann‐Lii Cheng, Chao A. Hsiung, et al. · Hepatology
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
2012 · Ann‐Lii Cheng, Zhongzhen Guan, et al. · European Journal of Cancer